Clareo Health | Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
18–49
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Documented surgical confirmation of endometriosis and associated moderate to severe pain.
Participants must agree to use dual non-hormonal methods of contraception consistently during washout (if applicable), screening, and 3-month double-blind placebo-controlled treatment periods of the study.
Participant, in the investigator's opinion must be an appropriate candidate to receive combined oral contraceptives (COCs).
You may not be if
Pregnant or breastfeeding or planning a pregnancy until completion of the study.
Surgical history of hysterectomy or bilateral oophorectomy.
Participant has osteoporosis or other metabolic bone disease or clinically significant gynecological findings from Screening.
Participant has any other active chronic pain condition that would interfere with their assessment of endometriosis-related pain.
